Genetic testing can help doctors choose the most effective and economical drugs to prevent blood clots in the half a million patients in the U.S. who receive coronary stents each year, according to a new study led by a UCSF researcher.

The Council for Advancement and Support of Education (CASE) has honored UC San Francisco with four awards in the 2014 CASE Awards of Excellence.

The UCSF community is invited to hear a diverse range of LGBTQI specialists in health care discuss a wide range of topics at a forum this Saturday, Feb. 22.